ABSTRACT
Objectives We assess the effectiveness of a visuomotor paired associative stimulation (vm-PAS) protocol targeting the Action Observation Network (AON) in patients with chronic post-stroke upper-limb hemiparesis. Vm-PAS consisted of hand-grasping action observation stimuli repeatedly paired with transcranial magnetic stimulation (TMS) pulses over the ipsilesional primary motor cortex (M1).
Methods Fifteen post-stroke patients underwent a session of the vm-PAS and, as a control, of the standard excitatory PAS (M1-PAS), during which slow-rate electrical stimulation of the paretic limb was paired with M1-TMS. Before and after each PAS, we assessed corticospinal excitability (CSE), short-interval intracortical inhibition (SICI), and paretic wrist’s voluntary movements.
Results The two protocols induce distinct muscle-specific CSE enhancements: vm-PAS increases motor- evoked potentials (MEPs) recorded from the paretic first dorsal interosseous muscle. Conversely, M1-PAS increases MEPs recorded from the electrically stimulated extensor carpi radialis muscle. Vm-PAS efficacy correlates with hemiparesis chronicity: the higher the time elapsed since the stroke, the greater vm-PAS effects on CSE. Neither protocol affected SICI or wrist movements.
Conclusion Vm-PAS leads to muscle-specific enhancements of CSE in post-stroke patients, highlighting its potential for driving post-stroke motor recovery.
Significance Our findings show the efficacy of a cross-modal PAS protocol targeting the AON in an injured motor system.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05766059
Funding Statement
This work was supported by Italian Ministry of Health - Ricerca Corrente. The project has been supported by the Grant 'PRIN 2022-NAZ-0168' from the Italian Ministry of University and Research to NB and GG.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of the IRCCS Istituto Auxologico Italiano gave ethical approval for this work (protocol number 25C212).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
